CD274 and nonpapillary renal cell carcinoma: This ccRCC model is resistant to immune therapy by anti-PD-1 antibody or small-molecule inhibitor of PD-1/PD-L1 interaction (Supplementary Fig. S3A, B) and therefore mimics ~80% of ccRCC patients who do not respond to immune therapy.